Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "Benefits"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"Canadian Agency for Drugs and Technologies in Health"
dewey-ones:"330 - Economics"
language:"English"
Showing
201
-
220
of
231
Search:
'"Benefits"'
,
query time: 0.04s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
201
Pharmacoeconomic review report: Sucroferric oxyhydroxide (Velphoro) (Vifor Fresenius Medical Care Renal Pharma Ltd.) : indication : for the control of serum phosphorus levels in ad...
Published 2019
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
202
Pharmacoeconomic review report: Ticagrelor (Brilinta)
Published 2016
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
203
Buprenorphine for opioid use disorder : a review of comparative clinical effectiveness, safety, cost-effectiveness, and guidelines
by
Marchand, Dave K.
,
Young, Calvin
,
Loshak, Hannah
Published 2019
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
204
Pharmacoeconomic review report: Sucroferric oxyhydroxide (Velphoro) (Vifor Fresenius Medical Care Renal Pharma Ltd.) : indication : for the control of serum phosphorus levels in ad...
Published 2019
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
205
Pharmacoeconomic review report: Dolutegravir (Tivicay)
Published 2014
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
206
CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus-Hoffmann-La Roche Limited) : indication : management of adult patients with early primary progressive mult...
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
207
Second- and third-line pharmacotherapy for type 2 diabetes : update of CADTH 2010 reviews :project protocol
Published 2012
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
208
Third-line pharmacotherapy for type 2 diabetes : update
Published 2013
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
209
CADTH Canadian Drug Expert Committee recommendation: Eliglustat (Cerdelga -- Sanofi Genzyme) : indication: Type 1 Gaucher disease
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
210
CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Rilpivirine (Juluca -- ViiV healthcare) : indication : the treatment of human immunodeficiency virus (HIV-1) infec...
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
211
CADTH Canadian Drug Expert Committee recommendation: Semaglutide (Ozempic -- Novo Nordisk Canada Inc.) : indication : diabetes mellitus, type 2 to improve glycemic control
Published 2019
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
212
CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Rilpivirine (Juluca -- ViiV healthcare) : indication : the treatment of human immunodeficiency virus (HIV-1) infec...
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
213
Radioembolization with yttrium-90 microspheres for the management of uveal melanoma liver metastases : a review of clinical effectiveness and cost-effectiveness
by
Ho, Chuong
,
McCormack, Suzanne
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
214
CADTH Canadian Drug Expert Committee recommendation: Netupitant/palonosetron (Akynzeo -- Purdue Pharma) : indication : chemotherapy-induced nausea and vomiting
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
215
Tesamorelin (Egrifta)
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
216
Screening for Chlamydia trachomatis and Neisseria gonorrhoeae during pregnancy : a health technology assessment
by
Kanga, Ismat
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
217
Screening for Chlamydia trachomatis and Neisseria gonorrhoeae during pregnancy : a health technology assessment
by
Kanga, Ismat
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
218
Heated humidified high flow oxygen for respiratory support : a review of clinical effectiveness, cost-effectiveness, and guidelines
by
Jahagirdar, Deepa
,
Picheca, Lory
Published 2019
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
219
Biologics dose escalation for the treatment of inflammatory bowel disease : a review of clinical effectiveness, cost-effectiveness, and guidelines
by
Chao, Yi-Sheng
,
Visintini, Sarah
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
220
Pharmacoeconomic review report: Safinamide (Onstryv) (Valeo Pharma Inc.) : indication: for add-on therapy to a regimen that includes levodopa for the treatment of the signs and sym...
Published 2020
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
2
3
4
5
6
7
8
9
10
11
12
Back
Narrow Search
Remove Filters
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Clear Filter
Classification: 330 - Economics
Clear Filter
Language: English
Year of Publication
From:
To:
Classification
330 - Economics
610 - Medicine & health
76
140 - Specific philosophical schools
19
700 - The arts; fine & decorative arts
17
580 - Plants (Botany)
3
600 - Technology
2
more ...
615 - Pharmacology & therapeutics
2
100 - Philosophy & psychology
1
363 - Other social problems & services
1
800 - Literature & rhetoric
1
see all ...
less ...
Language
English
Collection
National Center for Biotechnology Information
231
Author
Canadian Agency for Drugs and Technologies in Health
CADTH Canadian Drug Expert Committee
50
Canadian Agency for Drugs and Technologies in Health Rapid Response Service
27
Adcock, Lorna
7
Ho, Chuong
7
Ford, Caitlyn
6
more ...
Grobelna, Aleksandra
5
Argáez, Charlene
4
Chao, Yi-Sheng
4
Gray, Casey
4
McCormack, Suzanne
4
Tran, Khai
4
Banerjee, Srabani
3
Campbell, Kaitryn
3
Loshak, Hannah
3
MacDougall, Danielle
3
Wells, Charlotte
3
Williams, D.
3
Young, Calvin
3
Farrah, Kelly
2
Frey, Nina
2
Jahagirdar, Deepa
2
Kanga, Ismat
2
Poitras, Veronica
2
Visintini, Sarah
2
Adams, Alison
1
Chiu, Stephanie
1
Cowling, Tara
1
De Nanassy, Alina
1
Edge, Rob
1
Harricharan, Sharada
1
Khangura, Sara
1
Klarenbach, Scott
1
Krahn, Murray
1
La Fleur, Philip
1
Lachance, Chantelle
1
Lee, Karen M.
1
Marchand, Dave K.
1
Membe, Stephen K.
1
Narain, Tasha
1
Palylyk-Colwell, Eugenia
1
Picheca, Lory
1
Singh, Sumeet
1
Spry, Carolyn
1
Thompson, Wade
1
Wong, William
1
Wright, Mary-Doug
1
Yeung, Shirley S. T.
1
see all ...
less ...
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?page=11&filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&filter%5B%5D=dewey-ones%3A%22330+-+Economics%22&filter%5B%5D=language%3A%22English%22&lookfor=%22Benefits%22&type=Subject
Send by Email
×
Loading...